866-997-4948(US-Canada Toll Free)

North America Glucose Monitoring Market Outlook to 2022

Published By :

GlobalData

Published Date : Jan 2017

Category :

Medical Equipments

No. of Pages : 160 Pages

North America Glucose Monitoring Market Outlook to 2022

Summary

GlobalDatas new report, "North America Glucose Monitoring Market Outlook to 2022", provides key market data on the North America Glucose Monitoring market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Blood Glucose Meters, Blood Glucose Test Strips and Lancets.

The report also provides company shares and distribution shares data for each of these market segements, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Glucose Monitoring market segments - Blood Glucose Meters, Blood Glucose Test Strips and Lancets.
- Annualized market revenues (USD million) and volume (units) data for each of the market segements. Data is provided from 2008 to 2015 and forecast to 2022.
- 2015 company shares and distribution shares data for each of the market segements.
- Global corporate-level profiles of key companies operating within the North America Glucose Monitoring market.
- Key players covered include LifeScan Inc, Medtronic plc, Bayer HealthCare AG, F. Hoffmann-La Roche Ltd and Others.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and whats the most preferred mode of product distribution - Identify, understand and capitalize.
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 9
2.1 What Is This Report About? 9
2.2 Vision Care Market Segmentation 9
2.3 Definitions of Markets Covered in the Report 10
3 Glucose Monitoring Market, North America 11
3.1 Glucose Monitoring Market, North America, Revenue ($m), 2008-2022 11
3.2 Glucose Monitoring Market, North America, Category Comparison by Revenue ($m), 2008-2022 13
3.3 Glucose Monitoring Market, North America, Revenue ($m), 2008-2015 14
3.4 Glucose Monitoring Market, North America, Revenue ($m), 2015-2022 16
3.5 Glucose Monitoring Market, North America, Volume (Units), 2008-2022 18
3.6 Glucose Monitoring Market, North America, Volume (Units), 2008-2015 20
3.7 Glucose Monitoring Market, North America, Volume (Units), 2015-2022 22
3.8 Glucose Monitoring Market, North America, Company Share by Revenue ($m), 2015 24
4 Glucose Monitoring Market, Canada 26
4.1 Glucose Monitoring Market, Canada, Revenue ($m), 2008-2015 26
4.2 Glucose Monitoring Market, Canada, Revenue ($m), 2015-2022 28
4.2.1 Blood Glucose Meters Market, Canada, Revenue ($m), by Segment, 2008-2015 30
4.2.2 Blood Glucose Meters Market, Canada, Revenue ($m), by Segment, 2015-2022 32
4.3 Glucose Monitoring Market, Canada, Volume (Units), 2008-2015 34
4.4 Glucose Monitoring Market, Canada, Volume (Units), 2015-2022 36
4.4.1 Blood Glucose Meters Market, Canada, Volume (Units), by Segment, 2008-2015 38
4.4.2 Blood Glucose Meters Market, Canada, Volume (Units), by Segment, 2015-2022 40
4.5 Glucose Monitoring Market, Canada, Average Price ($), 2008-2022 42
4.6 Glucose Monitoring Market, Canada, Distribution Share by Revenue ($m), 2014-2015 43
4.7 Glucose Monitoring Market, Canada, Company Share by Revenue ($m), 2015 44
5 Glucose Monitoring Market, Mexico 46
5.1 Glucose Monitoring Market, Mexico, Revenue ($m), 2008-2015 46
5.2 Glucose Monitoring Market, Mexico, Revenue ($m), 2015-2022 48
5.2.1 Blood Glucose Meters Market, Mexico, Revenue ($m), by Segment, 2008-2015 50
5.2.2 Blood Glucose Meters Market, Mexico, Revenue ($m), by Segment, 2015-2022 52
5.3 Glucose Monitoring Market, Mexico, Volume (Units), 2008-2015 54
5.4 Glucose Monitoring Market, Mexico, Volume (Units), 2015-2022 56
5.4.1 Blood Glucose Meters Market, Mexico, Volume (Units), by Segment, 2008-2015 58
5.4.2 Blood Glucose Meters Market, Mexico, Volume (Units), by Segment, 2015-2022 60
5.5 Glucose Monitoring Market, Mexico, Average Price ($), 2008-2022 62
5.6 Glucose Monitoring Market, Mexico, Distribution Share by Revenue ($m), 2014-2015 63
5.7 Glucose Monitoring Market, Mexico, Company Share by Revenue ($m), 2015 64
6 Glucose Monitoring Market, United States 66
6.1 Glucose Monitoring Market, United States, Revenue ($m), 2008-2015 66
6.2 Glucose Monitoring Market, United States, Revenue ($m), 2015-2022 68
6.2.1 Blood Glucose Meters Market, United States, Revenue ($m), by Segment, 2008-2015 70
6.2.2 Blood Glucose Meters Market, United States, Revenue ($m), by Segment, 2015-2022 72
6.3 Glucose Monitoring Market, United States, Volume (Units), 2008-2015 74
6.4 Glucose Monitoring Market, United States, Volume (Units), 2015-2022 76
6.4.1 Blood Glucose Meters Market, United States, Volume (Units), by Segment, 2008-2015 78
6.4.2 Blood Glucose Meters Market, United States, Volume (Units), by Segment, 2015-2022 80
6.5 Glucose Monitoring Market, United States, Average Price ($), 2008-2022 82
6.6 Glucose Monitoring Market, United States, Distribution Share by Revenue ($m), 2014-2015 83
6.7 Glucose Monitoring Market, United States, Company Share by Revenue ($m), 2015 84
7 Overview of Key Companies in North America Glucose Monitoring Market 86
7.1 LifeScan Inc 86
7.1.1 Company Overview 86
7.2 Bayer HealthCare AG 86
7.2.1 Company Overview 86
7.3 Abbott Laboratories 86
7.3.1 Company Overview 86
7.4 F. Hoffmann-La Roche Ltd 87
7.4.1 Company Overview 87
7.5 DexCom Inc 87
7.5.1 Company Overview 87
7.6 Medtronic plc 87
7.6.1 Company Overview 87
7.7 Arkray Inc 87
7.7.1 Company Overview 87
7.8 Becton Dickinson and Co 88
7.8.1 Company Overview 88
7.9 Trividia Health Inc 88
7.9.1 Company Overview 88
8 Glucose Monitoring Market Pipeline Products 89
9 Recent Developments 91
9.1 Corporate Communications 91
9.1.1 Sep 20, 2016: Livongo Health Lands Dave Engberg from Evernote as Chief Technology Officer 91
9.1.2 Aug 16, 2016: One Drop Expands Diabetes Health and Behavioral Informatics Team With Addition of Chandra Osborn PhD, MPH as Vice President 91
9.1.3 Aug 02, 2016: PositiveID Adds GenArraytion CEO R. Paul Schaudies, Ph.D. to its Board of Advisors 92
9.1.4 Aug 01, 2016: Zynerba Pharmaceuticals Announces Dosing of First Patients in Phase 2 STAR 1 Clinical Study of ZYN002 CBD Gel in Adult Epilepsy Patients with Refractory Focal Seizures 93
9.1.5 Jul 28, 2016: BD Names R. Andrew Eckert To Board Of Directors 94
9.1.6 Jun 28, 2016: WellDoc, a Digital Health Technology Leader, Expands Leadership Team with Roster of Seasoned Healthcare Executives 95
9.1.7 Jun 22, 2016: Johnson & Johnson Announces Retirement of Louise Mehrotra and Appointment of Joseph Wolk as Vice President of Investor Relations 96
9.1.8 Mar 23, 2016: GlucoTrack Maker Names Two New Board Members 97
9.1.9 Mar 15, 2016: M Pharmaceutical Announces Change to Management 97
9.1.10 Feb 26, 2016: Clinical Update On Thetanix For The Treatment Of Paediatric Crohn Disease : 4D Pharma 97
9.1.11 Jan 28, 2016: LivaNova Receives Regulatory Approval in Japan for KORA 250 98
9.1.12 Jan 19, 2016: Johnson & Johnson Announces Actions To Strengthen Medical Devices Leadership Position In Evolving Healthcare Marketplace 99
9.1.13 Jan 08, 2016: BioGaias subsidiary IBT has US IND open and Swedish CTA approved for clinical study 100
9.2 Financial Announcements 101
9.2.1 Nov 21, 2016: PositiveID Reports Revenue of $4.6 Million for First Nine Months of 2016, Up 70% from $2.7 Million for First Nine Months of 2015 101
9.2.2 Nov 04, 2016: Alere Reports Third Quarter 2016 Financial Results 102
9.2.3 Nov 03, 2016: BD Announces Results For 2016 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2017 Guidance 102
9.2.4 Nov 01, 2016: Bio-Rad Reports Third-Quarter Currency-Neutral Revenue Growth of 9.1 Percent 104
9.2.5 Nov 01, 2016: DexCom Reports Third Quarter 2016 Financial Results 105
9.2.6 Oct 27, 2016: Thermo Fisher Scientific Reports Third Quarter 2016 Results 106
9.2.7 Oct 18, 2016: Johnson & Johnson Reports 2016 Third-Quarter Results 108
9.2.8 Sep 27, 2016: PositiveID Announces Highlights for Third Quarter 2016 110
9.2.9 Sep 06, 2016: Alere Reports Second Quarter 2016 Financial Results 111
9.2.10 Aug 17, 2016: Alere Reports First Quarter 2016 Financial Results 111
9.2.11 Aug 15, 2016: PositiveID Reports Q2 2016 Revenue of $1.8 Million, Up from $51 Thousand in Q2 2015 112
9.2.12 Aug 08, 2016: Alere Files Form 10-K, Reports Fourth Quarter and Full Year 2015 Financial Results 113
9.2.13 Aug 04, 2016: BD Announces Results For 2016 Third Fiscal Quarter 115
9.2.14 Aug 03, 2016: Bio-Rad Reports Second-Quarter 2016 Financial Results 116
9.2.15 Aug 02, 2016: DexCom Reports Second Quarter 2016 Financial Results 117
9.2.16 Jul 28, 2016: Thermo Fisher Scientific Reports Second Quarter 2016 Results 118
9.2.17 Jul 19, 2016: Johnson & Johnson Reports 2016 Second-Quarter Results 119
9.2.18 Jul 12, 2016: PositiveID Announces Highlights for First Half of 2016 121
9.2.19 Jun 06, 2016: Sangui BioTech: Third Quarter Report 122
9.2.20 Jun 02, 2016: Fuel3D announces first enterprise client scanning solution 123
9.2.21 May 17, 2016: PositiveID Reports Q1 2016 Revenue of $1.7 Million, Up from $0.1M in Q1 2015 124
9.2.22 May 05, 2016: BD Announces Results For 2016 Second Fiscal Quarter 124
9.2.23 Apr 27, 2016: DexCom Reports First Quarter 2016 Financial Results 126
9.2.24 Apr 19, 2016: Johnson & Johnson Reports 2016 First-Quarter Results 127
9.2.25 Apr 11, 2016: SteadyMed Announces Initiation Of Inter Partes Review Proceedings By U.S. Patent And Trademark Office Against A United Therapeutics Patent 128
9.2.26 Mar 10, 2016: Immunotherapeutic Potential of Manocept Platform Reviewed in the Journal Nuclear Medicine and Biology 130
9.2.27 Feb 23, 2016: DexCom Reports Fourth Quarter and Full Year 2015 Financial Results 132
9.2.28 Feb 03, 2016: BD Announces Results For 2016 First Fiscal Quarter 133
9.2.29 Jan 26, 2016: Johnson & Johnson Reports 2015 Fourth-Quarter Results 134
9.3 Legal And Regulatory 137
9.3.1 Dec 08, 2016: Khang & Khang Announces Securities Class Action Lawsuit against Alere and Reminds Investors with Losses to Contact the Firm 137
9.3.2 Dec 07, 2016: Abbott Seeks To Terminate Alere Acquisition 137
9.3.3 Aug 10, 2016: CDC Exercises Contract Option Valued at $11.6 Million to Further Support Emergent BioSolutions Vaccinia Immune Globulin 137
9.3.4 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 138
9.3.5 Mar 21, 2016: LifeWatch: Supplemental information on Highmark arbitration case 139
9.3.6 Mar 17, 2016: LifeWatch announces arbitration decision in Highmark case 140
9.3.7 Mar 14, 2016: DECN Subsidiaries Sue Johnson & Johnson and Several Divisions for Patent Infringement 140
9.3.8 Feb 29, 2016: Baron & Budd Investigating Potential Lawsuits Against Johnson & Johnson Regarding Link Between Talcum Powder and Ovarian Cancer 140
9.4 Other Significant Developments 141
9.4.1 Dec 14, 2016: One Drop Announces Inaugural Members Of One Drop | Experts Advisory Board 141
9.4.2 Oct 20, 2016: Actor Derek Theler and Dexcom Take Center Stage to Raise Awareness of Diabetes 143
9.4.3 Aug 17, 2016: Livongo for Diabetes Program Generates Positive Clinical, Financial Outcomes 144
9.4.4 Jun 21, 2016: PositiveIDs Mobile Lab Business Completed 80 Projects in the First Half of 2016 145
9.4.5 May 17, 2016: Protagonist Therapeutics to Present New Data on PTG-200 at Digestive Disease Week 2016 145
9.4.6 May 10, 2016: Thermo Fisher Scientific Reports Progress on Global Corporate Social Responsibility 146
9.4.7 May 03, 2016: Sentnyl Therapeutics, Re-Launches Abstral in the United States 147
9.4.8 Apr 06, 2016: Medtronic Statement on U.S. Department of Treasury's Recent Temporary and Proposed Regulations 147
9.5 Product News 147
9.5.1 Sep 12, 2016: Indiana University Research and Technology issued record 53 U.S. patents in 2015-16 147
9.5.2 Jun 28, 2016: Trividia Health Initiates Voluntary Recall of Certain Lots of TRUEread, TRUEbalance, TRUEtrack & TRUEtest blood glucose test strip 149
9.5.3 Apr 26, 2016: New Vigilant Diabetes Management Companion Launched in U.S. That Alerts Users to Risk of Severe Hypoglycemia in Next 24 Hours 150
9.5.4 Mar 09, 2016: Dexcom continuous glucose monitor receivers 151
9.6 Strategy And Business Planning 151
9.6.1 Nov 22, 2016: Highly Pathogenic Bird Flu Spreading Across Europe and Asia; BiondVaxs Universal Flu Vaccine Candidate Also Covers these Potential Pandemic Strains 151
9.6.2 Nov 14, 2016: Diabetes Management Leader Dexcom Expands Presence in EMEA Markets with new Edinburgh HQ 152
9.6.3 Jun 20, 2016: Dexcom to Expand Manufacturing Operations to Greater Phoenix, Arizona 153
9.6.4 Jan 25, 2016: AstraZeneca partners with peers and academia to establish translational research fund 154
9.6.5 Jan 21, 2016: Singularity University and BD Announce Collaboration Dedicated to Address Global Healthcare Challenges 154
10 Appendix 156
10.1 Research Methodology 157
10.1.1 Coverage 157
10.1.2 Secondary Research 157
10.1.3 Primary Research 158
10.1.4 Company Share Analysis 158
10.1.5 Distribution Share Analysis 158
10.1.6 Benchmarking 159
10.2 GlobalData Consulting 159
10.3 Contact Us 159
10.4 Disclaimer 160

List of Table

1.1 List of Tables
Table 1: Glucose Monitoring Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2008-2022 12
Table 2: Glucose Monitoring Market, North America, Category Comparison by Revenue ($m), USD Constant, 2008-2022 13
Table 3: Glucose Monitoring Market, North America, Revenue ($m), Historic, USD Constant, 2008-2015 15
Table 4: Glucose Monitoring Market, North America, Revenue ($m), Forecast, USD Constant, 2015-2022 17
Table 5: Glucose Monitoring Market, North America, Volume (Units), 2008-2022 19
Table 6: Glucose Monitoring Market, North America, Volume (Units), Historic, 2008-2015 21
Table 7: Glucose Monitoring Market, North America, Volume (Units), Forecast, 2015-2022 23
Table 8: Glucose Monitoring Market, North America, Company Share by Revenue ($m), USD Constant, 2015 25
Table 9: Glucose Monitoring Market, Canada, Revenue ($m), USD Constant, Historic, 2008-2015 27
Table 10: Glucose Monitoring Market, Canada, Revenue ($m), USD Constant, Forecast, 2015-2022 29
Table 11: Blood Glucose Meters Market, Canada, Revenue ($m), USD Constant, Historic, 2008-2015 31
Table 12: Blood Glucose Meters Market, Canada, Revenue ($m), USD Constant, Forecast, 2015-2022 33
Table 13: Glucose Monitoring Market, Canada, Volume (Units), Historic, 2008-2015 35
Table 14: Glucose Monitoring Market, Canada, Volume (Units), Forecast, 2015-2022 37
Table 15: Blood Glucose Meters Market, Canada, Volume (Units), Historic, 2008-2015 39
Table 16: Blood Glucose Meters Market, Canada, Volume (Units), Forecast, 2015-2022 41
Table 17: Glucose Monitoring Market, Canada, Average Price ($) Historic, 2008-2022 42
Table 18: Glucose Monitoring Market, Canada, Average Price ($), Forecast, 2015-2022 42
Table 19: Glucose Monitoring Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2014-2015 43
Table 20: Glucose Monitoring Market, Canada, Company Share by Revenue ($m), USD Constant, 2015 45
Table 21: Glucose Monitoring Market, Mexico, Revenue ($m), USD Constant, Historic, 2008-2015 47
Table 22: Glucose Monitoring Market, Mexico, Revenue ($m), USD Constant, Forecast, 2015-2022 49
Table 23: Blood Glucose Meters Market, Mexico, Revenue ($m), USD Constant, Historic, 2008-2015 51
Table 24: Blood Glucose Meters Market, Mexico, Revenue ($m), USD Constant, Forecast, 2015-2022 53
Table 25: Glucose Monitoring Market, Mexico, Volume (Units), Historic, 2008-2015 55
Table 26: Glucose Monitoring Market, Mexico, Volume (Units), Forecast, 2015-2022 57
Table 27: Blood Glucose Meters Market, Mexico, Volume (Units), Historic, 2008-2015 59
Table 28: Blood Glucose Meters Market, Mexico, Volume (Units), Forecast, 2015-2022 61
Table 29: Glucose Monitoring Market, Mexico, Average Price ($) Historic, 2008-2022 62
Table 30: Glucose Monitoring Market, Mexico, Average Price ($), Forecast, 2015-2022 62
Table 31: Glucose Monitoring Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2014-2015 63
Table 32: Glucose Monitoring Market, Mexico, Company Share by Revenue ($m), USD Constant, 2015 65
Table 33: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 67
Table 34: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 69
Table 35: Blood Glucose Meters Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 71
Table 36: Blood Glucose Meters Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 73
Table 37: Glucose Monitoring Market, United States, Volume (Units), Historic, 2008-2015 75
Table 38: Glucose Monitoring Market, United States, Volume (Units), Forecast, 2015-2022 77
Table 39: Blood Glucose Meters Market, United States, Volume (Units), Historic, 2008-2015 79
Table 40: Blood Glucose Meters Market, United States, Volume (Units), Forecast, 2015-2022 81
Table 41: Glucose Monitoring Market, United States, Average Price ($), Historic, 2008-2015 82
Table 42: Glucose Monitoring Market, United States, Average Price ($), Forecast, 2015-2022 82
Table 43: Glucose Monitoring Market, United States, Distribution Share by Revenue ($m), USD Constant, 2014-2015 83
Table 44: Glucose Monitoring Market, United States, Company Share by Revenue ($m), USD Constant, 2015 85
Table 45: Glucose Monitoring Market Pipeline Products 89

List of Chart

1.2 List of Figures
Figure 1: Glucose Monitoring Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2008-2022 11
Figure 2: Glucose Monitoring Market, North America, Category Comparison by Revenue ($m), USD Constant, 2008-2022 13
Figure 3: Glucose Monitoring Market, North America, Revenue ($m), Historic, USD Constant, 2008-2015 14
Figure 4: Glucose Monitoring Market, North America, Revenue ($m), Forecast, USD Constant, 2015-2022 16
Figure 5: Glucose Monitoring Market, North America, Volume (Units), 2008-2022 18
Figure 6: Glucose Monitoring Market, North America, Volume (Units), Historic, 2008-2015 20
Figure 7: Glucose Monitoring Market, North America, Volume (Units), Forecast, 2015-2022 22
Figure 8: Glucose Monitoring Market, North America, Company Share (%) 2015 24
Figure 9: Glucose Monitoring Market, Canada, Revenue ($m), USD Constant, Historic, 2008-2015 26
Figure 10: Glucose Monitoring Market, Canada, Revenue ($m), USD Constant, Forecast, 2015-2022 28
Figure 11: Blood Glucose Meters Market, Canada, Revenue ($m), USD Constant, Historic, 2008-2015 30
Figure 12: Blood Glucose Meters Market, Canada, Revenue ($m), USD Constant, Forecast, 2015-2022 32
Figure 13: Glucose Monitoring Market, Canada, Volume (Units), Historic, 2008-2015 34
Figure 14: Glucose Monitoring Market, Canada, Volume (Units), Forecast, 2015-2022 36
Figure 15: Blood Glucose Meters Market, Canada, Volume (Units), Historic, 2008-2015 38
Figure 16: Blood Glucose Meters Market, Canada, Volume (Units), Forecast, 2015-2022 40
Figure 17: Glucose Monitoring Market, Canada, Company Share (%) 2015 44
Figure 18: Glucose Monitoring Market, Mexico, Revenue ($m), USD Constant, Historic, 2008-2015 46
Figure 19: Glucose Monitoring Market, Mexico, Revenue ($m), USD Constant, Forecast, 2015-2022 48
Figure 20: Blood Glucose Meters Market, Mexico, Revenue ($m), USD Constant, Historic, 2008-2015 50
Figure 21: Blood Glucose Meters Market, Mexico, Revenue ($m), USD Constant, Forecast, 2015-2022 52
Figure 22: Glucose Monitoring Market, Mexico, Volume (Units), Historic, 2008-2015 54
Figure 23: Glucose Monitoring Market, Mexico, Volume (Units), Forecast, 2015-2022 56
Figure 24: Blood Glucose Meters Market, Mexico, Volume (Units), Historic, 2008-2015 58
Figure 25: Blood Glucose Meters Market, Mexico, Volume (Units), Forecast, 2015-2022 60
Figure 26: Glucose Monitoring Market, Mexico, Company Share (%) 2015 64
Figure 27: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 66
Figure 28: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 68
Figure 29: Blood Glucose Meters Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 70
Figure 30: Blood Glucose Meters Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 72
Figure 31: Glucose Monitoring Market, United States, Volume (Units), Historic, 2008-2015 74
Figure 32: Glucose Monitoring Market, United States, Volume (Units), Forecast, 2015-2022 76
Figure 33: Blood Glucose Meters Market, United States, Volume (Units), Historic, 2008-2015 78
Figure 34: Blood Glucose Meters Market, United States, Volume (Units), Forecast, 2015-2022 80
Figure 35: Glucose Monitoring Market, United States, Company Share (%) 2015 84

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *

Upcoming Reports